About
Dr. Kim has extensive experience in life sciences operations as well as scientific research. He is Founding Managing Director of the Korea-Seoul Life Science Fund (KSLSF). He is responsible for all aspects of investment, portfolio support and Fund operations of KSLSF. Dr. Kim's investments include PharmAbcine (member of BOD, mAb therapies for cancer), Pathway Genomics (personalized genetic testing, San Diego), CrystalGenomics (KOSDAQ listed, small molecules to treat inflammation, infection and cancer). Prior to joining OBP in 2009, Dr. Kim served as Associate Director and Head of Operations for the global BioMarker Development group at the Novartis Institutes for BioMedical Research. He held an additional role in corporate development and strategy while at Novartis. Previously, Dr. Kim was a member of the IBM Extreme Blue program, providing strategic direction for IBM Healthcare and Life Sciences. At Alkermes, he conducted preclinical pharmacology research to evaluate proprietary drug
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like B.
Search Investors